116 related articles for article (PubMed ID: 10374484)
1. [The effects of IFN-gamma on the antitumor abilities of immunocytes and chemotherapeutic agents].
Gu Q; Zhu Z; Yin H
Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):89-91. PubMed ID: 10374484
[TBL] [Abstract][Full Text] [Related]
2. Interferon-induced increase in sensitivity of ovarian cancer targets to lysis by lymphokine-activated killer cells: selective effects on HER2/neu-overexpressing cells.
Fady C; Gardner AM; Gera JF; Lichtenstein A
Cancer Res; 1992 Feb; 52(4):764-9. PubMed ID: 1346583
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.
Okamoto T; Tsuburaya A; Yanoma S; Yoshikawa T; Cho H; Takanashi Y; Noguchi Y
Anticancer Res; 2003; 23(1A):149-53. PubMed ID: 12680206
[TBL] [Abstract][Full Text] [Related]
4. [An experimental study of the antitumor activity of tumor-infiltrating lymphocytes (TIL) in human tongue carcinoma in vitro].
Guo W
Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Sep; 27(5):259-61, 318. PubMed ID: 1306434
[TBL] [Abstract][Full Text] [Related]
5. Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.
Frost P; Caliliw R; Belldegrun A; Bonavida B
Int J Oncol; 2003 Feb; 22(2):431-7. PubMed ID: 12527945
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells.
Baral E; Nagy E; Krepart GV; Lotocki RJ; Unruh HW; Berczi I
Anticancer Res; 2000; 20(3B):2027-31. PubMed ID: 10928146
[TBL] [Abstract][Full Text] [Related]
9. [Experimental study of adoptive immunotherapy for adenoid cystic carcinoma of the salivary gland].
Li X; Zhou Z; Peng Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Sep; 31(5):271-3. PubMed ID: 9592252
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model.
Lefor AT; Fabian DF
J Surg Res; 1998 Feb; 75(1):49-53. PubMed ID: 9614856
[TBL] [Abstract][Full Text] [Related]
11. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
Wang Z; Cheng Y; Zheng R; Qin D; Liu G
Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
[TBL] [Abstract][Full Text] [Related]
12. [Experimental studies on the antitumor activity of glioma-infiltrating lymphocytes against autologous glioma].
Li Y
Zhonghua Yi Xue Za Zhi; 1992 May; 72(5):284-6, 319. PubMed ID: 1327462
[TBL] [Abstract][Full Text] [Related]
13. Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Gazit Z; Weiss DW; Shouval D; Yechezkeli M; Schirrmacher V; Notter M; Walter J; Kedar E
Cancer Immunol Immunother; 1992; 35(2):135-44. PubMed ID: 1596937
[TBL] [Abstract][Full Text] [Related]
14. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of antitumor activity of tumor draining lymph node lymphocytes and peripheral blood lymphocytes in human oral cancer].
Guo W; Qiu WL; He RG
Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Nov; 29(6):336-8, 384. PubMed ID: 7743875
[TBL] [Abstract][Full Text] [Related]
16. Postoperative immunotherapy for patients with hepatocarcinoma using tumor-infiltrating lymphocytes.
Wang Y; Chen H; Wu M; Bao J; Cong W; Wang H
Chin Med J (Engl); 1997 Feb; 110(2):114-7. PubMed ID: 9594281
[TBL] [Abstract][Full Text] [Related]
17. Control mechanisms of cell-mediated reactions.
Salerno A; Sireci G; Dominici R; Bonanno CT; Caccamo N; Dieli F
Wien Klin Wochenschr; 1996; 108(8):244-7. PubMed ID: 8686315
[TBL] [Abstract][Full Text] [Related]
18. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
Guo YS; Xing ZL
Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
[TBL] [Abstract][Full Text] [Related]
19. [Cytotoxicities of low dose anticancer agents combining lymphokine activated killer cell against ovarian adenocarcinoma cell line SKOV3].
Chen R; Pan L; Zhou S
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):172-4. PubMed ID: 11263191
[TBL] [Abstract][Full Text] [Related]
20. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
Ohshita A; Yamaguchi Y; Minami K; Okita R; Toge T
Int J Oncol; 2006 May; 28(5):1163-71. PubMed ID: 16596232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
